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This work details the intentional modifications that led to the first structure of
a type III glutamine synthetase enzyme (GSIII). This approach followed the
serendipitous discovery of digestion caused by an extracellular protease from a
contaminating bacterium, Pseudomonas fluorescens. The protease only cleaves
the GSIII protein at a single site, leaving the oligomer intact but allowing the
protein to crystallize in a different space group. This transition from space group
P1 to space group C2221 is accompanied by improved growth characteristics,
more reproducible diffraction and enhanced mechanical stability. The crystallo-
graphic analyses presented here provide the structural basis of the altered
molecular packing in the full-length and digested crystal forms and suggest
modifications for future structural studies.
1. Introduction
The largest of the glutamine synthetase (GS) enzymes, the type III
glutamine synthetases (GSIIIs), occur in evolutionarily diverse
species (Xu et al., 2003; Goodman & Woods, 1993; Amaya et al., 2005;
Southern et al., 1986; Kinoshita et al., 2009). However, until recently
only low-resolution structural information existed to describe them
(van Rooyen et al., 2006). We have recently determined the first
crystal structure of a large (1 MDa) GSIII enzyme from Bacteroides
fragilis and the results (van Rooyen et al., 2011) have helped to
explain the evolution of the important GS superfamily and have
highlighted several strategies for targeting these divergent enzymes
through rational drug design. Our success was greatly facilitated by
the serendipitous discovery of proteolysis-mediated changes at the
surface of the GSIII dodecamers which allowed the protein to crys-
tallize in a higher symmetry space group. It was from these crystals
that the latter structure solution resulted. Here, we detail the
discoveries that led to this result and reveal the underlying molecular
alterations that are responsible for the substantial changes in crystal
packing.
2. Methods and materials
2.1. Protein isolation
Pure recombinant B. fragilis GSIII was prepared from an
Escherichia coli heterologous expression host using a combination
of divalent-cation precipitation and affinity chromatography as
described previously (van Rooyen et al., 2010).
2.2. Isolation of a bacterial protease
An inoculum of the contaminating bacteria was isolated from
crystallization plates which lacked bacteriostatics. Subsequent
cultures were grown on Luria–Bertani (LB) agar plates or in 5 ml
volumes of LB broth at 294 K without aeration. The bacterial
contaminant was identified as Pseudodomonas fluorescens following
16s rRNA gene sequencing by Macrogen Inc., Seoul, Republic of
Korea. The universal primers F27 (50-AGAGTTTGATCITGGCT-
CAG-30) and R5 (50-ACGGITACCTTGTTACGACTT-30) (Chèneby
# 2011 International Union of Crystallography
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et al., 2000) were used during PCR and sequences were analysed
using BLAST v.2.2.17 (Altschul et al., 1990).
The culture supernatant (CS) was prepared from a 5 ml culture of
P. fluorescens grown in LB and incubated at 294 K for 2 d. After
centrifugation of the culture for 15 min at 14 000 rev min1 in a
desktop centrifuge, the CS was stored at 253 K and used in all
subsequent proteolysis experiments.
2.3. Protease-susceptibility assays
Aliquots of 4 mg ml1 GSIII in 15 mM imidazole pH 7.1 were
mixed with an equal volume of P. fluorescens CS (serial doubling
dilution in dH2O) and incubated at 294 K for 16 h. Digestion was
halted by the addition of gel-loading buffer and the samples were
analyzed by SDS–PAGE. An untreated sample of GSIII was incu-
bated at 294 K for 24 h to serve as a negative control. Enzyme activity
was monitored by the gamma-glutamyltransferase assay as modified
by Southern et al. (1986).
2.4. Identification of proteolysis products
In-gel tryptic digestion and MALDI–TOF mass-spectrometric
fingerprinting of the resulting peptides were carried out using
established protocols (Rosenfeld et al., 1992). Mass spectra were
collected on an ABI 4800 MALDI–TOF/TOF machine in reflection
positive mode operating at 20 kV source voltage and 16 kV grid
voltage with a 400 ns delayed extraction time. A default calibration
was applied and a scan range of 800 to 4000 m/z was used to collect
data with 50 shots per subspectrum and a total of 1000 spectra. Data
processing was carried out using GPS EXPLORER software from
ABI and proteins were identified using the Mascot web server.
2.5. Characterization of digested GSIII complex
GSIII protein (10 mg ml1) digested with P. fluorescens super-
natant as described above and an undigested control were loaded
separately onto a Tosoh PWXL-4000 column pre-equilibrated with
0.1 M citric acid/0.05 M NaH2PO4 pH 5.8 and 100 mM KCl at
0.4 ml min1. The column had previously been calibrated using high-
molecular-weight standards from Bio-Rad, 3%(v/v) acetone and
TMV. Identical samples (1 mg) were also mixed with gel-loading
buffer without SDS and -mercaptoethanol for analysis by discon-
tinuous native PAGE (Ornstein, 1964) with 2.5% acrylamide stacking
and 4% acrylamide separating gels.
2.6. Crystallization of digested GSIII
Proteolysis was achieved by mixing equal volumes of P. fluorescens
CS with pure GSIII (6 mg ml1 in the final affinity-chromatography
elution buffer; van Rooyen et al., 2010) and incubating for 16 h at
room temperature. The digested protein was then reconcentrated and
buffer-exchanged (three times to one fifth of the volume) in equili-
bration buffer using a 100 kDa molecular-weight cutoff Nanosep
centrifugal concentrator (Pall Corporation) to give a final concen-
tration of 3.5 mg ml1. Crystallization was achieved by using the same
conditions that had proved to be successful for the full-length GSIII
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Figure 1
Alternate crystal forms resulting from limited proteolysis of GSIII. (a) Coomassie Blue-stained 10% SDS–PAGE gel of the proteolysis products (48 and 32 kDa) resulting
from the addition of different concentrations of P. fluorescens culture supernatant to semi-pure GSIII (96 kDa). Molecular-weight standards were loaded into the lane
marked S and their weights are given in kDa on the left. (b) Size-exclusion chromatograph of digested (red) and undigested (blue) GSIII. Inset, full-length (control) and
digested GSIII were also analysed by native PAGE. (c) Crystals of full-length and digested (cross-seeded) GSIII grown under identical conditions. (d) Oscillation images (1)
of the full-length (P1) and digested (C2221) GSIII crystals. Data collection was performed as described in x2.7. The maximum recorded resolution was 2.9 Å and the contrast
levels of the images were adjusted for presentation purposes.
protein (van Rooyen et al., 2010) and growth was initiated by cross-
seeding with nuclei from crystals of the latter. Further batches
of crystals were prepared by streak-seeding equilibrated drops
(1.75 mg ml1 digested GSIII) with nuclei from these new crystals.
Crystal growth to about 0.1 mm was achieved in 2–4 d.
2.7. Data collection and processing of the full-length GSIII protein
All crystallographic data were collected on the BM14 beamline at
the ESRF, Grenoble, France as described in van Rooyen et al. (2010).
Complete data sets were collected to 3 Å resolution at 100 K from a
P1 native crystal and a C2221 digested crystal of similar dimensions
(0.1  0.1  0.1 mm) that were preserved under optimized cryo-
conditions (Paratone-N oil). A custom-designed low-resolution
beamstop developed by the UK MRC–EMBL Grenoble teams was
used and allowed low-resolution data set to be collected to 130 Å for
the C2221 case; it was fitted during both experiments. In addition,
during the characterization of the different crystal forms an HC1b
humidity-control device was used to vary the relative humidity (RH)
during data collection (Sanchez-Weatherby et al., 2009). MicroRT
capillaries (MiTeGen) were also used to initially evaluate room-
temperature diffraction from each crystal form.
Initial indexing and evaluation of the data quality were carried out
with iMOSFLM (Leslie, 2006) and space-group assignments were
evaluated with POINTLESS (Evans, 2006). Scaling, reduction and
merging of the C2221 diffraction data were carried out using SCALA
(Evans, 2006) within the CCP4 suite (Collaborative Computational
Project, Number 4, 1994). The final integration, scaling and merging
of the P1 data was performed using XDS (Kabsch, 2010).
2.8. Crystal-packing analysis
The dodecameric biological unit of the digested GSIII structure
(PDB code 3o6x; van Rooyen et al., 2011) was used as a search model
for molecular replacement of the full-length data using MOLREP
(Vagin & Teplyakov, 2010) from the CCP4 suite (Collaborative
Computational Project, Number 4, 1994). The most promising solu-
tion was then subjected to rigid-body refinement in CNS (Brünger et
al., 1998), treating each of the 12 protomers as individual rigid bodies.
This maximum-likelihood refinement was carried out over ten cycles
with 20 rounds of minimization, each with overall anisotropic
B-factor and bulk-solvent corrections, resulting in a decrease in Rfree
from 0.47 to 0.37.
Symmetry-related neighbours within 10 Å of atoms in the asym-
metric unit were generated from both the P1 and C2221 (van Rooyen
et al., 2011) structures using PyMOL (DeLano, 2002). Crystal
contacts were then identified in UCSF CHIMERA (Pettersen et al.,
2004) using the CLASH/CONTACT plugin with a van der Waals
overlap limit of 3.5 Å. Additional calculations to ascertain the
changes in surface area upon oligomerization and crystallization were
carried out in AREAIMOL (Collaborative Computational Project,
Number 4, 1994; Lee & Richards, 1971) with a solvent probe radius of
1.4 Å.
All molecular renderings were performed in UCSF Chimera
(Pettersen et al., 2004).
3. Results and discussion
3.1. Limited proteolysis
During the isolation of GSIII (van Rooyen et al., 2010) it was
serendipitously discovered that a bacterial contaminant in the protein
preparation was secreting a protease that was capable of nicking the
protein at a surface-exposed site. Under denaturing conditions, the
digested GSIII protein yielded two peptides with masses of around 48
and 35 kDa. Following the isolation of these peptide products using
SDS–PAGE, the identity of the larger fragment was confirmed as an
N-terminal fragment of GSIII using peptide-fingerprinting mass
spectroscopy.
The bacterial contaminant was isolated and cultured. The sequence
of its 16s rRNA gene identified it as P. fluorescens, which is known
to secrete an extracellular protease (Liao & McCallus, 1998). The
culture supernatant was tested for activity and the resultant peptide
masses matched those seen in the contaminated protein stock
(Fig. 1a). Further characterization of the protease activity showed
that proteolysis by the P. fluorescens culture supernatant did not
progress to further digestion even after prolonged storage (two
weeks) at 277 K. Size-exclusion chromatography confirmed this by
showing that the complex remained intact after digestion (Fig. 1b),
but the higher resolution of native PAGE revealed a slight change
in the mass–charge ratio (Fig. 1b, inset). However, similar digestions
with trypsin yielded the same-sized products after short incubations,
but longer timescales resulted in complete digestion of GSIII (results
not shown). Estimates of the proteolytic cleavage site near residue
430 were made from the masses of the intact fragments derived from
MALDI–TOF mass spectrometry (32 874 and 48 360 Da) and the
known GSIII sequence (Hill et al., 1989). It is well known that
proteolytic sensitive sites are generally solvent-exposed extended
loops and that their mobility is the primary determinant of protease
susceptibility (Hubbard, 1998). In keeping with the masses of the
fragments, it therefore seemed likely that the cleavage results in the
loss of a surface-exposed loop near residue 430.
3.2. Improved crystals
Proteolytic treatment under nondenaturing conditions has become
a standard strategy for modifying crystallization behaviour (Newman,
2006). By removing the intrinsically disordered surface loops that
contribute significantly towards conformational heterogeneity, the
likelihood of a protein crystallizing can be increased. Crystallization
of the digested complex was therefore attempted in the hope that the
modified GSIII complex might yield higher quality crystals. Crystal
crystallization communications
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Table 1
Data-collection statistics.
Values in parentheses are for the highest resolution shell.
Crystal data
Space group C2221 P1†
Unit-cell parameters (Å, ) a = 198.25, b = 203.96,
c = 234.59,
 =  =  = 90.00
a = 141.79, b = 148.30,
c = 159.33,  = 115.76,
 = 93.65,  = 115.99




No. of molecules in
asymmetric unit
6 12
Solvent content (%) 48.99 53.02
Data collection
Resolution range (Å) 62.87–3.50 (3.69–3.50) 130.0–3.5 (3.69–3.50)
No. of unique reflections 60104 (8687) 123636 (18005)
No. of observed reflections 471192 (68419) 490235 (71612)
Completeness (%) 100 98.3 (98.0)
Multiplicity 7.8 4.0
Signal to noise 11.2 (4.6) 12.3 (4.6)
Rmerge‡ (%) 20.8 (47.2) 10.9 (32.5)
Rp.i.m. (all I
+ and I) (%) 7.9 (17.9) 6.3 (18.9)
Wilson B factor (Å2) 45.0 62.1
† Data were scaled to 3.5 Å resolution to facilitate comparison with the C2221 crystal
form, but molecular replacement and rigid-body refinement included data to









trials of digested GSIII were carried out using the same conditions
that proved successful for the full-length enzyme and similar protein
concentrations (van Rooyen et al., 2010). Cross-seedings using nuclei
from the full-length crystals were able to produce large individual
crystallization communications
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Figure 2
Digestion of a surface-exposed loop leads to improved molecular packing in the higher symmetry crystal form. (a) Crystal-packing diagrams comparing the arrangement of
dodecamers in the alternate lattices. The unit cell is shown in black and the subunits in the biological asymmetric unit are highlighted in different colours. (b) Crystal-contact
changes resulting from proteolysis. The GSIII asymmetric unit is shown in thick C-trace representation and symmetry-related molecules within 10 Å are shown in thin
C-trace representation. Only one ring of the dodecamer in the P1 form is shown. Residues of the dodecamer which approach closer than 3.5 Å to symmetry-related
neighbouring molecules are highlighted in red. Arrows mark the positions of contacts involving the region of protease susceptibility.
crystals that displayed a clearly different bipyramidal habit after
several days of growth (Fig. 1c).
Room-temperature experiments showed that the two crystal forms
diffracted weakly to 3.5 Å resolution, with the full-length GSIII
protein and the digested protein crystallizing in space groups P1 and
C2221, respectively (Fig. 1d and Table 1). At this temperature, the
crystals exhibited radiation-sensitivity, only surviving 100 s in the
bending-magnet synchrotron beam; the diffraction quality between
crystals was somewhat variable but was routinely better for the larger
C2221 crystals (Fig. 1d and Table 1). The latter crystals also displayed
a reversible transition during in situ dehydration experiments with
the HC1b device. While the P1 crystals lost all diffraction upon
dehydration below 90% RH, the C2221 crystals regained their upper
resolution diffraction limit when returned to 98% RH for 5 min (data
not shown). These results confirmed the previously noted fragility of
the P1 crystals in comparison to the more robust C2221 form, which
were less likely to fracture during manual manipulation.
Cryoprotection in standard buffers containing 20% PEG 400 and
25% glycerol resulted in a reduction of the diffraction limit to 7 Å for
both crystal forms following flash-cooling in a cryostream (data not
shown). It was subsequently determined that these crystals only lost
order during the freezing process, as they still diffracted to 3.5 Å at
ambient temperature in MicroRT capillary mounts after soaking
in 30% glycerol for 15 min. Following a systematic assessment of
cryoconditions, Paratone-N oil was found to be the only easily
reproducible method of preserving higher resolution diffraction from
both the P1 and C2221 crystal forms during flash-freezing in the
cryostream or in liquid nitrogen.
3.3. Crystallographic identification of the protease-susceptible site
Following the solution of the X-ray crystal structure from the
C2221 crystal data (van Rooyen et al., 2011), it has been possible to
map the site of proteolytic sensitivity near residue 430 to a region of
missing density at the tips of the subunits of the dodecameric GSIII
structure. As predicted from its amino-acid sequence, this 33-residue
region appears to be disordered; no additional density could be seen
in the P1 (full-length) electron-density maps and the temperature
factors were highest at the ends of the pinwheel arms in the C2221
structure (van Rooyen et al., 2011). The protease-sensitivity and the
change in mobility of GSIII seen on native PAGE can therefore be
explained by the accessibility and flexibility of this loop region.
3.4. Effects of altered crystal packing
Using the refined 3.5 Å resolution GSIII crystal structure (van
Rooyen et al., 2011), it has also been possible to examine the
underlying changes that are responsible for the differences in mole-
cular packing following digestion. Although the P1 structure was not
refined to atomic detail, the results of the molecular-replacement and
rigid-body refinement analyses presented here reveal the effects of
proteolysis on the molecular contacts between the component
dodecamers in the two crystal forms (Fig. 2a). The P1 crystal form
is made up of layers of GSIII dodecamers arranged in a hexagonal
fashion in the ab plane. These layers then stack on top of each other
in an offset manner, with the large flat surfaces of the GSIII conical
domes fitting into each other like saw teeth (Fig. 2a; P1, a0c0 and b0c0
views). In the C2221 crystals the dodecamers are also arranged in
parallel arrays with the principal axes of the GSIII dodecamers
aligning with the crystallographic axes (Fig. 2a; C2221, bc view).
However, when viewed from the ac plane it can be seen that every
alternate layer is composed of parallel arrays of molecules arranged
with their sixfold axes tilted in opposite directions from the c axis
(Fig. 2a; C2221, ac view).
The predominant packing interface formed by the large domed
surface in both crystals is composed of a central hydrophobic stripe
which is surrounded on either side by charged residues (van Rooyen
et al., 2011). These surfaces are formed by the helical bundles which
make up the spokes of the ‘pinwheel’ arms. It is therefore likely that
these surface features are also responsible for the resolution-limiting
preferential attachment of GSIII to the carbon support film and air–
water interface observed during electron-microscopy studies (van
Rooyen et al., 2006).
It can be seen from these analyses that the protease-susceptibility
site located at the tips of the pinwheel arms contributes to crystalline
packing through the formation of several crystal contacts with
neighbouring dodecamers (Fig. 2b). In the P1 crystal these regions
interact primarily with adjacent dodecamers in the same layer.
However, after proteolysis the nature of the interaction changes,
resulting in a greater number of contacts between the molecules of
the asymmetric unit and adjacent dodecamers (Fig. 3). The total
crystallization communications
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Figure 3
Increase in crystal-packing contact areas following digestion. Axial views of the GSIII hexamers (van Rooyen et al., 2011) comprising the asymmetric units of both crystal
forms are shown in thick C-trace representation. Residues which approach closer than 3.5 Å to symmetry-related neighbouring molecules are coloured red.
surface area buried upon crystallization increases from 2771 Å2 in the
P1 crystal form to 5056 Å2 in the C2221 crystal form (excluding the
inter-ring interactions), i.e. there is almost a doubling of packing-
contact area. These changes to the crystalline order therefore explain
the improved mechanical stability and growth characteristics of the
orthorhombic crystals.
In conclusion, the GSIII enzyme possesses a surface-exposed
flexible loop, the cleavage of which by an extracellular protease from
P. fluorescens does not alter the oligomeric structure but does change
the surface properties. This modification is sufficient, under the same
crystallization conditions, to alter the crystal-packing interactions and
leads to the formation of a crystal form with higher symmetry,
improved mechanical properties and enhanced growth character-
istics. We propose that the truncation of this region by limited
proteolysis or genetic manipulation will facilitate the solution of
many more GSIII enzymes. The accessibility, low cost and specificity
of the low-temperature protease from P. fluorescens may also prove
useful to experimentalists wishing to modify other proteins in
preparation for crystallization.
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